What do specialty pharmaceutical company Depomed Inc (NASDAQ:DEPO) and biotechnology company Celgene Corporation (NASDAQ:CELG) have in common? Both stocks have recently received bullish outlooks from analysts weighing in.
As Intercept Pharmaceuticals Inc (NASDAQ:ICPT) approaches a crucial date for FDA approval of a liver disease treatment and Rexahn Pharmaceuticals, Inc (NYSE:RNN) announces its YE15 earnings …
Analysts offer commentary on cannabinoid pharmaceutical company GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH) and biopharm firm Relypsa Inc (NASDAQ:RLYP) with differing opinions. One analyst sings GWPH’s …
Analysts separately explain why they are bullish on both Celgene Corporation (NASDAQ:CELG) and Regulus Therapeutics Inc (NASDAQ:RGLS) as Celgene works to expand the …
Analysts have mixed sentiments on MannKind Corporation (NASDAQ:MNKD) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). It’s a long fall from the top as MannKind investors …
Cowen & Co healthcare analysts provide updates following successful phase three trial for Exelixis, Inc.’s (NASDAQ:EXEL) drug, Cabozantinib, and Avalanche Biotechnologies Inc’s (NASDAQ:AAVL) …
Analysts weigh in with bullish sentiments on both Incyte Corporation (NASDAQ:INCY) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) following the termination of the drug trial …
On Sep 21, Gilead Sciences, Inc. (NASDAQ:GILD) announced data from four of its Phase 3 studies: ASTRAL-1, ASTRAL-2, ASTRAL-3 and ASTRAL-4, for the …
In a research report released today, Cowen’s healthcare analyst Ritu Baral reiterated an Outperform rating on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), and raised the price …
Analysts weighed in on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with bullish sentiments following the company’s investor meeting this week.